Press Releases InMed Announces Appointment of Joshua Blacher as Chief Business Officer April 11, 2018 Read More » InMed Pharmaceuticals Announces Graduation to Toronto Stock Exchange March 23, 2018 Read More » InMed Appoints Dr. Eric Hsu as Vice President, Preclinical Research and Development March 13, 2018 Read More » InMed to Present at 30th Annual ROTH Capital Conference March 12, 2018 Read More » InMed Announces Peer-Reviewed Publication in Drug Delivery and Translational Research March 6, 2018 Read More » InMed Receives Conditional Approval to List on the Toronto Stock Exchange March 2, 2018 Read More » InMed To Present At Canaccord Genuity Conference January 23, 2018 Read More » InMed Closes Over-Subscribed C$9.4 Million Financing January 4, 2018 Read More » InMed Clarifies 3rd Party News Coverage December 20, 2017 Read More » InMed Announces Non-Brokered Private Placement December 18, 2017 Read More » InMed to Present at Cannabis-Based Science & Medicine Conference November 16, 2017 Read More » InMed Announces Positive Pre-Clinical Data on an Ocular Hydrogel Formulation using a Biosynthesized Cannabinoid October 24, 2017 Read More » InMed Updates Pain Program October 17, 2017 Read More » InMed Appoints Dr. Mauro Maccarrone to its Scientific Advisory Board October 10, 2017 Read More » InMed Pharmaceuticals Files Provisional Patent for Pain Program October 3, 2017 Read More » InMed Continues to Make Significant Strides on Biosynthesis Program Development September 25, 2017 Read More » InMed Pharmaceuticals Added to CSE25 Index September 21, 2017 Read More » InMed Retains Consultant Ben Paterson for Biosynthesis Development September 19, 2017 Read More » InMed Files Provisional Patent for Biosynthesis of Cannabinoids September 12, 2017 Read More » InMed Announces Appointment of Creative Capital Media August 18, 2017 Read More » « Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Next » Management Learn More Board of Directors Learn More Scientific Advisory Board Learn More Investor Alerts Sign up to receive news releases from InMed Pharmaceuticals. SIGN UP
InMed Appoints Dr. Eric Hsu as Vice President, Preclinical Research and Development March 13, 2018 Read More »
InMed Announces Peer-Reviewed Publication in Drug Delivery and Translational Research March 6, 2018 Read More »
InMed Announces Positive Pre-Clinical Data on an Ocular Hydrogel Formulation using a Biosynthesized Cannabinoid October 24, 2017 Read More »
InMed Continues to Make Significant Strides on Biosynthesis Program Development September 25, 2017 Read More »
